Kunkun Wang

Dr. Kunkun Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
MLMengyan Li
Mengyan Li
RRRuodi Ren
Ruodi Ren
KWKunkun Wang
Kunkun Wang
SWShan Wang
Shan Wang
ACAllison Chow
Allison Chow
CLChristopher Leo
Christopher Leo
Homocysteine is an amino acid derived from methionine which is metabolized via vitamin B6 (pyridoxine)- and vitamin B12 (cobalamin)-dependent pathways. Supplementation of B vitamins has been shown to effectively reduce plasma homocysteine levels. Previous research has also demonstrated an association between lower plasma homocysteine levels and decreased risk of myocardial infarction, stroke, and venous thromboembolism. However, whether supplementation of B vitamins is associated with risk reduction in thromboembolic events and confers clinical benefits remains inconclusive. This review examines clinical trials published over the past 29 years to assess the effects of B vitamin supplementation on thrombotic risk reduction and homocysteine metabolism. The findings from these studies are inconsistent, and the impact of B vitamins on thrombosis prevention remains uncertain. Given the conflicting evidence, further clinical and translational research is necessary to clarify the role of B vitamin supplementation in thrombosis risk reduction.

12 August 2024 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
HTHeqing Tao
Heqing Tao
LLLigang Liu
Ligang Liu
JCJiayu Cui
Jiayu Cui
KWKunkun Wang
Kunkun Wang
LPLiang Peng
Liang Peng
MNMilap C. Nahata
Milap C. Nahata

27 February 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
SWShan Wang
Shan Wang
RRRuodi Ren
Ruodi Ren
KWKunkun Wang
Kunkun Wang
CLChristopher Leo
Christopher Leo
MLMengyan Li
Mengyan Li
YLYun Lu
Yun Lu
The prevalence of vitamin D deficiency among intensive care unit (ICU) patients is potentially associated with an increased risk of mechanical ventilation, sepsis, prolonged hospital stays, and mortality. Although ICU patient care has significantly improved in recent years, the role of vitamin D supplementation remains under investigation. A literature review was conducted using PubMed, Web of Science, Embase, and Cochrane databases, focusing on randomized controlled trials published in the past five years on vitamin D supplementation in adult ICU patients. Patients’ baseline vitamin D levels, administration routes, doses, biomarker changes, mechanical ventilation duration, length of hospital stay, and mortality were analyzed. Although vitamin D supplementation appears safe and may reduce ICU stay duration and mechanical ventilation time and improve SOFA scores, its impact on overall mortality remains uncertain. Routine supplementation for all ICU patients is not currently recommended; clinical decisions should consider individual baseline vitamin D levels, patient characteristics, severity of illness, doses, and administration methods.

23 April 2022 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
KWKunkun Wang
Kunkun Wang
LYLing Yin
Ling Yin
YSYang Song
Yang Song
MZMengqi Zhang
Mengqi Zhang
YLYun Lu
Yun Lu
SWShan Wang
Shan Wang
Background: Sepsis and septic shock are associated with enormous mortality and health care burden. Since the study of Marik et al suggested mortality benefit, there has been great interest in evaluating the role of hydrocortisone, ascorbic acid and thiamine (HAT therapy) in sepsis and septic shock. Purpose: The objective of this article is to review current literature of using HAT therapy in sepsis and septic shock, and discuss the findings in hospital mortality, change in 72 hr SOFA score, other outcomes, and the study limitations. Research Design: Three databases (PubMed, Embase, and Cochrane) were screened using predefined search terms ascorbic acid, vitamin C, thiamine, vitamin B1, hydrocortisone, sepsis, septic shock. Study Sample: Data extracted from eligible studies include authors, publication year, sample size, study design, intervention, outcome measures and study results. Each study was reviewed critically. Results: Among 11 studies included in this literature review, 3 studies reported HAT therapy was associated with mortality benefit, 1 reported hospital mortality was significantly higher in HAT group and the rest of studies didn’t reach statistical significance in mortality analysis. Significant improvement of secondary outcomes, although not consistently, were reported. Conclusions: In conclusion, HAT therapy has demonstrated a good safety profile and potential benefits in management of sepsis and septic shock. Further research is required to confirm these findings.

1 January 2026 in Journal of Obesity
Verified
Journal Article
Open access
LLLigang Liu
Ligang Liu
HTHeqing Tao
Heqing Tao
HZHao Zhao
Hao Zhao
JWJie Wang
Jie Wang
KWKunkun Wang
Kunkun Wang
MNMilap C. Nahata
Milap C. Nahata
Background: Dietary supplements are commonly marketed for weight loss, yet contemporary national data remain limited on the prevalence of use, types of products used, and whether use is provider‐recommended among U.S. adults with obesity. Methods: We conducted a cross‐sectional analysis using data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2020. Participants included adults with obesity. They were asked about behaviors on dietary supplements for weight loss. We estimated survey‐weighted prevalence overall and by survey cycle, assessed linear trends over time, and used survey‐weighted multivariable logistic regression to examine associations with age, sex, race/ethnicity, education, and poverty–income ratio. Among users, we described whether supplement use was recommended by healthcare providers and summarized supplement categories. Results: Among 27,116 adults with obesity, 1706 reported using dietary supplements for weight loss. The survey‐weighted prevalence of weight‐loss supplement use was 5.9% and varied across survey cycles ( p for trend = 0.003). Compared with adults aged 20–39 years, odds of use were lower among those aged 40–59 years (adjusted odds ratio [aOR] 0.60, 95% CI 0.45–0.80) and ≥ 60 years (aOR 0.15, 95% CI 0.11–0.22). Females had higher odds of use than males (aOR 1.46, 95% CI 1.13–1.87). Education was positively associated with use, whereas poverty–income ratio was not significantly associated. The use differed by race/ethnicity, with non‐Hispanic White adults having lower odds of use compared with Hispanic adults. Among users, 81% reported use without medical advice, and it was more common among males and younger adults. The most frequently used supplements included multivitamin–minerals (28.8%), botanical products (20.0%), and single vitamins (15.2%). Conclusions: Approximately 6% of U.S. adults with obesity reported using dietary supplements for weight loss, most without clinician recommendation and with significant demographic differences. Routine clinical assessment of supplement use and counseling regarding limited efficacy and potential safety concerns are warranted.

9 November 2022 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
KWKunkun Wang
Kunkun Wang
YLYun Lu
Yun Lu
MSMengistu A Simegn
Mengistu A Simegn
HXHaoran Xue
Haoran Xue
RARichard W Asinger
Richard W Asinger